SEC Form D · filed May 10, 2019
Novus Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Ken Miller · ROXBORO, NCDirectorRichard H. Hardwick · Dallas, TXExec · DirectorPaolo Crozzoli · Luxembourg, LuxembourgDirectorJohn Mcbride · Irvine, CADirectorAlphonse L. Iudicello · Chicago, ILDirectorJon Kuwahara · Irvine, CAExecCorey D. Linn · KENNEDY SPACE CENTER, FLExecCharles Laurans · Boston, MAExec · DirectorJames F. Connor · Menlo Park, CADirector[No Name] Boyd Watterson GSA GP, LLC · Cleveland, OHDirectorFrederick Brumder · Bend, ORDirectorKathleen L. Herrin · Chicago, ILDirector[No Name] Boyd Watterson Asset Management, LLC · Cleveland, OHExecJohn Lykouretzos · NEW YORK, NYDirectorKeith Katkin · Irvine, CADirectorCatherine Turkel · Irvine, CAExecStefan Goetz · London, United KingdomExecMatthew E. Rydell · Dallas, TXDirectorErez Chimovits · Irvine, CADirectorCheryl Cohen · Irvine, CADirectorGregory Flesher · Irvine, CAExec · DirectorGary Lyons · Irvine, CADirectorAndrew D. Cooper · Phoenix, AZDirectorJerret H. Shuck · Dallas, TXExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗